R医药股份有限公司股权激励计划的方案设计研究

发布时间：2018-07-12 16:23

本文选题：股权激励计划 + 激励机制　；参考：《哈尔滨工业大学》2017年硕士论文

【摘要】：股权激励计划作为一种长期有效的激励方式,能有效地增加公司管理层的经营动力,进而服务于股东投资目标,已被西方广泛的应用于公司实践并取得不错效果。但是,在我国这方面的理论研究和实践发展的并不理想。R医药公司是A药集团旗下的医药商业平台,总部位于黑龙江省哈尔滨市,公司的主营业务主要由医药批发业务及医药零售业务构成,是黑龙江省药品流通行业龙头企业,但是R医药公司现有的激励机制中存在着一些问题,并且由于这些问题导致R医药公司面临股东权益受损、优秀人才缺失的风险。为了应对这种风险,适应经济环境及公司的需求,本文希望通过对R医药公司的激励机制进行设计改善,为公司引进股权激励计划这种激励方式,为公司未来发展吸引并留住更多的“生力军”,使公司长远可持续地发展下去。本文参考了国内外学者相关研究成果,并且对R医药公司的经营概况和所处省市经济情况及行业情况特点进行了简明扼要的了解,对R医药公司的激励机制进行深入分析研究,之后对R医药公司的当前激励机制体系中存在的不足及问题做了梳理和更深入的分析,发现R医药公司存在着管理层过度规避风险损害股东利益、激励效果低、精神激励不足、绩效考核指标设计不完善等问题,在充分了解研究R医药公司的当前内外部环境的基础上,提出对R医药公司实施股权激励计划并为其设计,本文主要对股权激励计划的具体内容进行设计,分别从股权激励的模式、股票来源、授予价格、授予对象、时限安排、激励额度、考核指标七个方面进行科学合理地设计,结合2014-2015年已经发布的股权激励计划与R医药公司的实际情况,主要对股权激励计划的行权指标选取、指标标准的确定进行研究,致力于使R医药公司股权激励计划达到最优状态。最后,对于股权激励计划实施过程中可能遇到的障碍提出合理可行的建议。
[Abstract]:As a long-term and effective incentive scheme, equity incentive plan can effectively increase the management power of the company and serve the shareholders' investment target. It has been widely used in western companies and achieved good results. However, the development of theoretical research and practice in this area in China is not ideal. R Pharmaceutical Company is the pharmaceutical business platform of A Pharmaceutical Group, which is headquartered in Harbin City, Heilongjiang Province. The company's main business is mainly composed of pharmaceutical wholesale business and pharmaceutical retail business. It is a leading enterprise in the pharmaceutical circulation industry in Heilongjiang Province. However, there are some problems in the existing incentive mechanism of R Pharmaceutical Company. And as a result of these problems, R Pharmaceutical Company is faced with the risk of losing shareholders' rights and talents. In order to deal with this risk and adapt to the economic environment and the needs of the company, this paper hopes to design and improve the incentive mechanism of R Pharmaceutical Company to introduce the equity incentive plan for the company. To attract and retain more fresh forces for the future development of the company, so that the company can continue to develop in the long run. This article has consulted the domestic and foreign scholars' related research results, and has carried on the concise understanding to the R medicine company's management general situation, the province economic situation and the profession situation characteristic, has carried on the thorough analysis to the R medicine company's incentive mechanism. After that, the author combs and analyzes the problems in the current incentive mechanism system of R Pharmaceutical Company, and finds that the management of R Pharmaceutical Company has the advantages of excessive avoiding risk, harming shareholders' interests, low incentive effect and insufficient spiritual incentive. On the basis of fully understanding the current internal and external environment of R pharmaceutical company, this paper puts forward the equity incentive plan for R pharmaceutical company and designs it. This paper mainly designs the specific contents of the equity incentive plan, respectively from seven aspects of equity incentive mode, stock source, award price, granting object, time limit arrangement, incentive quota, assessment index, scientific and reasonable design. Combined with the actual situation of R Pharmaceutical Company and the stock incentive plan published in 2014-2015, this paper mainly studies the selection of the exercise index and the determination of the index standard of the equity incentive plan. Committed to R Pharmaceutical Company equity incentive plan to achieve optimal state. Finally, some reasonable and feasible suggestions are put forward for the obstacles that may be encountered in the implementation of the equity incentive plan.
【学位授予单位】：哈尔滨工业大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：F272.92;F721

【参考文献】